Aaron Mitchell, MD, MPH, medical oncologist and health outcomes researcher at Memorial Sloan Kettering Cancer Center, comes on to discuss the shortcomings and pitfalls of the regulatory processes at the FDA, optimal trial endpoints that provide the strongest evidence for approval, whether the accelerated approval process is enforced as it is written, what power any advisory panel really has when it comes to FDA approvals, and so many more pain points today.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
